Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Sep 09, 2024
Helicobacter pylori infection is among the most widespread chronic bacterial infections globally, affecting roughly half of the world’s population. H. pylori is classified as a Class I carcinogen by the WHO and is recognized as a qualifying pathogen under the US FDA’s GAIN Act. It is the most significant known risk...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper